EP4426298
Nýjar meðferðarsamsetningar sem innihalda pírfenídón og PDE4-hindra til meðhöndlunar á ágengum bandvefsmyndandi millivefs-lungnasjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.12.2022EP published:
11.2.2026EP application number:
22839143.9
EP translation filed:
18.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
7.12.2042Expiry date:
7.12.2026
Title in English:
NEW THERAPEUTIC COMBINATIONS COMPRISING PIRFENIDONE AND PDE4-INHIBITOR FOR THE TREATMENT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASESLanguage of the patent:
English
Timeline
Today
8.12.2022EP application
11.2.2026EP Publication
18.3.2026Translation submitted
8.4.2026Registration published
7.12.2026Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
HESSLINGER, ChristianAddress:
55216 Ingelheim am Rhein, DE
Name:
BAUER, VerenaAddress:
55216 Ingelheim am Rhein, DE
Name:
BOSSERT, Sebastian MartinAddress:
55216 Ingelheim am Rhein, DE
Name:
KOBER, SusanAddress:
55216 Ingelheim am Rhein, DE
Name:
LIU, YiAddress:
Ridgefield, Connecticut 06877-0368, US
Name:
NICKOLAUS, PeterAddress:
55216 Ingelheim am Rhein, DE
Name:
SARNO, MariaAddress:
55216 Ingelheim am Rhein, DE
Name:
VOSS, FlorianAddress:
55216 Ingelheim am Rhein, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202163287641 PDate:
9.12.2021Country:
US
Number:
21218207Date:
29.12.2021Country:
EP
Number:
22177757Date:
8.6.2022Country:
EP
Classification
Categories:
A61K 31/4418, A61K 31/496, A61K 31/519, A61P 11/00